hyoscyamine has been researched along with triamcinolone in 1 studies
Studies (hyoscyamine) | Trials (hyoscyamine) | Recent Studies (post-2010) (hyoscyamine) | Studies (triamcinolone) | Trials (triamcinolone) | Recent Studies (post-2010) (triamcinolone) |
---|---|---|---|---|---|
99 | 1 | 55 | 4,098 | 408 | 896 |
Protein | Taxonomy | hyoscyamine (IC50) | triamcinolone (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 0.058 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.058 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 9.47 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.058 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.058 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.058 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 9.47 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
1 other study(ies) available for hyoscyamine and triamcinolone
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |